Hot penny stocks... don't get burned
   

News for Acadia Pharmaceuticals, Inc (ACAD)

Markets Quote Depth/LII Options Charts News Profile Financials Insiders Filings Analyst Earnings Historical
Symbol: powered by
  quotemedia.com
News for ACADIA Pharmaceuticals Inc.  (ACAD) 
|
$ 2.82      0.42 (+17.50%) Volume: 203.87 k 4:00 PM EDT Sep 5, 2008
After Hours:  $ 2.81   -0.01 (-0.35%) Volume: 400 4:00 PM EDT Sep 5, 2008
Fri, Sep 05, 2008
4:59 PM ACADIA Pharmaceuticals Files Registration Statement as Required by Previously Announced Committed Equity Financing Facility - Business Wire
Thu, Aug 28, 2008
9:09 AM ACADIA Pharmaceuticals to Present at The Thomas Weisel Partners Healthcare Conference on September 4, 2008 - Business Wire
Tue, Aug 05, 2008
8:34 AM ACADIA Pharmaceuticals Secures Committed Equity Financing Facility - Business Wire
8:14 AM ACADIA Pharmaceuticals Announces Second Quarter 2008 Financial Results and Strategic Restructuring - Business Wire
Tue, Jul 29, 2008
5:01 PM ACADIA Pharmaceuticals to Announce Second Quarter 2008 Financial Results on August 5, 2008 - Business Wire
Mon, Jun 16, 2008
7:37 AM ACADIA Pharmaceuticals Announces Results from ACP-104 Phase IIb Schizophrenia Trial - Business Wire
Wed, Jun 04, 2008
9:18 AM ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences - Business Wire
Wed, May 14, 2008
9:16 AM ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences - Business Wire
Mon, May 05, 2008
4:06 PM ACADIA Pharmaceuticals Reports First Quarter 2008 Financial Results - Business Wire
10:28 AM ACADIA Pharmaceuticals Announces Election of Laura A. Brege to Board of Directors - Business Wire
Wed, Apr 30, 2008
9:06 AM ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences - Business Wire
Mon, Apr 28, 2008
9:12 AM ACADIA Pharmaceuticals to Announce First Quarter 2008 Financial Results on May 5, 2008 - Business Wire
Wed, Apr 16, 2008
9:11 AM ACADIA Pharmaceuticals to Present Data from Its Phase II Trial with Pimavanserin for Parkinson's Disease Psychosis at the 60th American Academy of Neurology Annual Meeting - Business Wire
Fri, Apr 04, 2008
9:06 AM ACADIA Pharmaceuticals to Present Preclinical Data on ACP-104, ACP-105 and Its Muscarinic Discovery Program at Experimental Biology 2008 Meeting - Business Wire
Mon, Mar 31, 2008
10:33 AM ACADIA Pharmaceuticals Initiates Second Phase III Trial with Pimavanserin in Patients with Parkinson's Disease Psychosis - Business Wire
Fri, Mar 28, 2008
9:32 AM ACADIA Pharmaceuticals to Present at the 8th Annual Fortis Bank Biotechnology Conference - Business Wire
Wed, Oct 10, 2007
9:28 AM Gilead Paid Lobbyist $150,000 in 2007 and QLT Acquires Eading Edge Ocular Drug Delivery System from ForSight Labs - U.S. Equity News
Tue, Jun 12, 2007
9:47 AM (OTC: KALG) Announces Discovery of Additional Coal Seams - Marketwire
Wed, Jun 06, 2007
11:55 AM Investment News Alerts: Wednesday's Stocks Worth Watching -- Energy Sector Skyrockets! - Marketwire
Wed, Apr 04, 2007
11:46 AM TBI Therapeutics Reviewed by NeuroInvestment - Marketwire
Mon, Mar 26, 2007
10:19 AM (OTC: MNCL) Starts Negotiations to Enter the Australian Market - Marketwire
Wed, Mar 07, 2007
9:00 AM Schizophrenia Therapeutics Reviewed by NeuroInvestment - Marketwire
Mon, Feb 05, 2007
9:00 AM Parkinson's Therapeutics Reviewed by NeuroInvestment - Marketwire
Tue, Sep 05, 2006
9:00 AM Neuropathic Pain Treatments Reviewed by NeuroInvestment - Marketwire
Tue, Jul 18, 2006
7:30 AM (OTC: QTCE) Assumes Delivery of Its Web-Marketing Products to PartyGaming.com, World's Leading Online Gaming Company - Marketwire
  Page 1 of 2   Next Page

Copyright © QuoteMedia.   Data delayed at least 15 min. unless otherwise indicated.   RT   Realtime,  EOD   End Of Day,  PD   Previous Day.   Market Data powered by QuoteMediaTerms of Use. 
   
Research Report
Hotstocked.com has a complete research report available for ACAD stock. Download ACAD report.
Research Report
Get the full report for FREE
Date:Sep 2, 2008
Price:Free
Pages:4
Document Type:Adobe Acrobat Reader
 Download ACAD report
  
Example preview: Research report for Acadia Pharmaceuticals, Inc (ACAD) Research report for Acadia Pharmaceuticals, Inc (ACAD) Research report for Acadia Pharmaceuticals, Inc (ACAD) Research report for Acadia Pharmaceuticals, Inc (ACAD)
   
   
   
Attention: Please help us to improve our services by answering the following poll:



Please Leave a comment to tell us how you think we can improve our services.

Your message:
   
   
   
   

SPKL shot up 21%


From: OTC Journal
Added: 22 Sep, 2007

   

Add to Google
Add to My Yahoo!
rss
 
 
Home > Companies > Acadia Pharmaceuticals, Inc